The Clearity Foundation

In memory of our visionary and founder, Susan Poorman Blackie, and in honor of National Ovarian Cancer Awareness Month, the Susan Poorman Blackie Ovarian Cancer Foundation has made a special two-year gift of $100,000 per year to The Clearity Foundation to support their mission to change the treatment paradigm for ovarian cancer patients.  This investment is especially meaningful because Susan wholeheartedly believed in Clearity’s mission and was eager to support their innovative work.  It is made possible, in part, by the many donations generously and kindly given in memory of Susan’s life.

 “Your investment over the next two years will be critical in allowing Clearity to provide more patients and their physicians with tumor profile information to inform treatment decisions. In addition, your support will enable us to accelerate research in partnership with preeminent medical centers to improve ovarian cancer treatment in the future,” states Hillary Theakston, Clearity’s Executive Director.

Launched in 2008, The Clearity Foundation helps ovarian cancer patients and their physicians make better-informed treatment decisions based on the molecular profile of their tumor.  Their goal is to help women with recurrent ovarian cancer live longer, healthier lives through individualized treatment.

This promising partnership is the first of many to continue honoring Susan’s commitment to changing the way this disease is detected and treated and her wish to empower all women and families affected by ovarian cancer.

Read more about The Clearity Foundation and tumor blueprints here.